1 Finally we also present a possible strategy based on loss eng
2 Finally, we believe that this work is an example of the impac
3 Finally, we confirmed low 25D plasma levels in patients with
4 Finally, we consider the implications for rational drug devel
5 Finally, we consider the limitations of this form of analysis
6 Finally, we demonstrate that changes in the size of the D3-D4
7 Finally, we demonstrate that co-targeting of ROS1 and EGFR co
8 Finally, we demonstrate that MAPPIN outperforms CADD and Eige
9 Finally, we demonstrated that JAM-C controls Src family kinas
10 Finally, we demonstrated that systemic application of antibio
11 Finally, we describe a novel form of activity-dependent intri
12 Finally, we develop a statistical model that incorporates the
13 Finally, we discuss how modern detection and diagnostic techn
14 Finally, we discuss major challenges and open questions relat
15 Finally, we discuss the current and future impact of AMDs on
16 Finally, we discuss the implications of GPCR conformational p
17 Finally, we evaluated the capacity of anti-receptor monoclona
18 Finally, we examine possibilities of engineering hormone cros
19 Finally, we found that FXYDs in extant vertebrates can be cla
20 Finally, we found that methylation at multiple CpG sites in t
21 Finally, we found that ST8Sia-IV autopolysialylation is requi
22 Finally, we generate time-lapse movies of complex neural arbo
23 Finally, we had people read real science news items and found
24 Finally, we have estimated the n2 in a large wavelength range
25 Finally, we identify an association between high MCAM levels
26 Finally, we identify and compare appropriate tunable-by-dopin
27 Finally, we identify the challenges that the field currently
28 Finally, we introduce a preparation of peripheral nerve slice
29 Finally, we offer a perspective on the future developments of
30 Finally, we present novel dendroecology-based estimates of sh
31 Finally, we present outstanding questions.
32 Finally, we present the ongoing debate on the possibility of
33 Finally, we quantified prevalence and abundance of putatively
34 Finally, we report that BEC-1/BECN1/Beclin1 functions non-cel
35 Finally, we report the use of molecular modeling simulations
36 Finally, we show evidence for the requirement of VASP to form
37 Finally, we show that CCAR2 is required for proliferation in
38 Finally, we show that FC involving cortico-thalamic pathways
39 Finally, we show that in live S2 cells, ABS2 and ABS3 are eac
40 Finally, we show that knockdown of EmMBD2/3 expression disrup
41 Finally, we show that USP36 down-regulation alters cell proli
42 Finally, we show that V. fischeri, purified EroS, and other b
43 Finally, we show that Zfp106 potently suppresses neurotoxicit
44 Finally, we show why the described mechanisms are relevant no
45 Finally, we showed that A-kinase anchoring proteins play an e
46 Finally, we showed that ABCD4 lysosomal targeting depends on
47 Finally, we track the fate of seedlings of an encroaching shr
48 Finally, we utilized the expanded cerebral organoids to show
49 Finally, we validate the ubiquitous nature of urea-aromatic s
50 Finally, we vaped a surface in the laboratory and used our me